ONC News

Latest ONC News

• Luxury Goods on Path to Revenue Growth, Says Goldman Sachs
  Gilan Miller-Gertz · Oct 25, 2026
• ONICO Faces Upholding of Biofuel Penalty but Sees Liability Cut to PLN 1.04 Million
  TipRanks Poland Auto-Generated Newsdesk · Oct 24, 2026
• Oncoclínicas Files Revised R$5.7 Billion Out-of-Court Recovery Plan
  TipRanks Brazil Auto-Generated Newsdesk · Oct 23, 2026
• BeOne Medicines Completes Key Sonrotoclax Formulation Study, Trimming Early-Stage Risk
  TipRanks Clinical-Trials-Auto-Generated Newsdesk · Oct 23, 2026
• Barclays Sticks to Their Buy Rating for Moncler S.p.A. (0QII)
  TipRanks Auto-Generated Intelligence Newsdesk · Oct 23, 2026
• RBC Capital Sticks to Its Hold Rating for Moncler S.p.A. (0QII)
  TipRanks Auto-Generated Intelligence Newsdesk · Oct 23, 2026
• BeOne Medicines Ltd (6160) Receives a Buy from UBS
  TipRanks Auto-Generated Intelligence Newsdesk · Oct 21, 2026
• Oncolytics Showcases Pelareorep Phase 2 mCRC Study Plans
  TipRanks Auto-Generated Newsdesk · Oct 20, 2026
• Oncolytics Showcases Pelareorep Phase 2 mCRC Study Plans
  TipRanks Auto-Generated Newsdesk · Oct 20, 2026
• Analysts Offer Insights on Healthcare Companies: Illumina (ILMN), United Therapeutics (UTHR) and BeOne Medicines (ONC)
  TipRanks Newsroom · Oct 18, 2026
• BeOne Medicines (ONC) Receives a Buy from RBC Capital
  TipRanks Auto-Generated Intelligence Newsdesk · Oct 17, 2026
• BeOne Medicines (ONC) Receives a Buy from RBC Capital
  TipRanks Auto-Generated Intelligence Newsdesk · Oct 17, 2026
• Borsa Istanbul Triggers Circuit Breaker in ONCOSEM Shares
  TipRanks Turkey Auto-Generated Newsdesk · Oct 16, 2026
• Bernstein Keeps Their Buy Rating on Moncler S.p.A. (0QII)
  TipRanks Auto-Generated Intelligence Newsdesk · Oct 15, 2026
• Oncoclínicas Launches Independent Probe Into Prior Management’s Deals
  TipRanks Brazil Auto-Generated Newsdesk · Oct 14, 2026
• Oncolytics Biotech Updates GOBLET Gastrointestinal Cancer Study
  TipRanks Auto-Generated Newsdesk · Oct 14, 2026
• Oncolytics Biotech Extends Pelareorep Patent Protection Into Late 2040s
  TipRanks Canadian Auto-Generated Newsdesk · Oct 12, 2026
• Company Moves to Exit Venture Stake in Oncosem via Borsa İstanbul Share Sale
  TipRanks Turkey Auto-Generated Newsdesk · Oct 12, 2026
• Truist Financial Remains a Buy on BeOne Medicines (ONC)
  TipRanks Auto-Generated Intelligence Newsdesk · Oct 9, 2026
• BeOne Medicines Advances BGB-43395 With New Drug Interaction Study Update
  TipRanks Clinical-Trials-Auto-Generated Newsdesk · Oct 8, 2026